APA (7th ed.) Citation

G, R., C, S., T, A., S, F., & N, A. (2021). Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination. Journal of pediatric hematology/oncology, 43(7), e1045. https://doi.org/10.1097/MPH.0000000000002099

Chicago Style (17th ed.) Citation

G, Revon-Riviere, Soler C, Andrianarivony T, Fily S, and André N. "Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination." Journal of Pediatric Hematology/oncology 43, no. 7 (2021): e1045. https://doi.org/10.1097/MPH.0000000000002099.

MLA (9th ed.) Citation

G, Revon-Riviere, et al. "Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination." Journal of Pediatric Hematology/oncology, vol. 43, no. 7, 2021, p. e1045, https://doi.org/10.1097/MPH.0000000000002099.